2nd Annual Clinical Risk Management For Emerging Companies, October 24, 2023, Virtual Event, Build an Effective Clinical Risk Management Strategy Using Available Resources to Achieve a Confident State of GCP Inspection Readiness
Become a Sponsor for 2023
See 2022 Agenda
Save The Date
Logo of 2nd Annual Clinical Risk Management for Emerging Companies Logo

This year we heard our esteemed speaking faculty share experiences on how to build and initiate effective clinical quality risk management strategies for emerging companies through Expert Panels, Workshops, and Networking Sessions.

Thank you to our conference Chair and Speaking Faculty

Sharon Reinhard
Sharon Reinhard
Vice President, Global Quality

AVROBIO

Allison Duran
Allison Duran
Associate Director, Clinical Oversight and Optimization

SANGAMO THERAPEUTICS

Karen Harvey
Karen Harvey
Senior Director

WCG AVOCA QUALITY CONSORTIUM

Anne Marie Inglis
Anne Marie Inglis
Executive Director, Clinical Operations

AFFINIVAX

Marci Macpherson
Marci Macpherson
Executive Director, Quality Assurance and Compliance

IONIS PHARMACEUTICALS

Leslie Sam
Leslie Sam
President

LESLIE SAM AND ASSOCIATES, LLC

Sarah Silvers, MS, RQAP-GCP
Sarah Silvers, MS, RQAP-GCP
Former Senior Director, GCP Quality Assurance

SANBIO

Michelle Webb
Michelle Webb
Vice President

WCG AVOCA QUALITY CONSORTIUM

Michele Weitz
Michele Weitz
Executive Director, Clinical Standards and Innovation

CLOVIS ONCOLOGY

Thank you to our 2022 Sponsor and Consortium Partner

The Avoca Group
WCG Avoca Quality Consortium

2023 Sponsorship Opportunities Are Open

Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

For more details on sponsorship and exhibition opportunities, please contact Michael Williams at michael@momentumevents.com

Become a Sponsor for 2023

Top Reasons to Attend

Reason one to attend

Assess clinical risk using available resources to guide the development of your clinical risk management plan

Reason two to attend

Utilize mock inspections as a quality tool to focus risk mitigation efforts

Reason three to attend

Understand the current regulatory environment and the critical elements of changing regulations that impact clinical quality risk management

Reason four to attend

Implement quality measurement tools such as tolerance limits and key indicators to maintain compliance

Reason five to attend

Discuss best practices for vendor oversight and how to ensure your partners focus on quality

Reason six to attend

Identify best practices for building quality into your culture and processes from the start

Reason seven to attend

Achieve a constant state of inspection readiness with already available tools and resources

Reason eight to attend

Engage with your peers on real life examples of issue identification and management

Save The Date

WHO SHOULD ATTEND

This event is developed for professionals from pharmaceutical, biotechnology and medical device companies, CROs, clinical service and technology providers as well as those professionals from sites who have responsibilities in any the following areas:

  • Quality Management/ Clinical Quality Management
  • Clinical Quality Assurance/ QA/ CQA
  • Clinical Quality Control/ QC/ CQC
  • Quality Operations/ Quality Systems/ Quality Processes
  • Clinical Operations/ Management/ Research/ Development
  • Compliance/ Clinical Compliance/ Regulatory Compliance
  • Auditing
  • Inspection/ Inspection Readiness
  • Clinical Outsourcing/ Vendor Oversight and Management/ Strategic Partnerships/ Third-Party Management and Oversight
  • Clinical Risk/ Quality Risk/ Risk Assessment/ Risk Management
  • Site Monitoring/ Site Management/ Study Management/ Trial Management
  • Good Clinical Practice/ GCP
  • Clinical Data
  • Regulatory Affairs